Lupin launches patient support program ‘Jeet’ dedicated to heart-health

16 Aug 2023 Evaluate

Lupin has launched Jeet, its patient support program dedicated to heart-health. The initiative launch coincides with India’s 76th Independence Day, symbolizing freedom from disease-related stress and a journey towards a happier and healthier life. Jeet will be a trusted partner in cardiovascular care, offering a range of benefits including savings on medical costs, disease counselling, medication reminders and lifestyle support.

Jeet can be accessible through the Play or App Store, as well as the website https://lupinjeet.com. Jeet offers a comprehensive approach to enhancing the doctor-patient experience by raising awareness about cardiovascular ailments and associated co-morbid conditions. The program includes features designed to encourage healthier lifestyle choices and provides support and care for a healthy heart. Jeet ensures timely medication reminders and promotes daily health and wellness activities including interactions that resonate with patients.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

2120.00 -1.65 (-0.08%)
29-Jan-2026 13:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1597.90
Dr. Reddys Lab 1200.00
Cipla 1319.40
Zydus Lifesciences 887.50
Lupin 2120.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×